GSK Licenses Shigella Vaccine Candidate to Bharat Biotech

Published on 12/06/2025 at 16:34

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about GSK plc

GSK plc Provides Update on US FDA Advisory Committee Review of Blenrep (belantamab Mafodotin-blmf) Combinations	06:51pm	CI
Bristol Myers' drug fails main goal in cancer-related anemia trial	06:29pm	RE
There's joy in the air	06:24pm
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Strong Economic Data	06:06pm	MT
FTSE 100 set for fourth week of gains as Burberry soars	04:49pm	RE
FTSE 100 gain tempered as GSK tanks	04:37pm	AN
European shares rise as investors focus on earnings	03:28pm	RE
European shares rise as investors focus on earnings	03:28pm	RE
GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt	03:10pm	DJ
GSK Says US FDA Committee Votes Against Blood Cancer Drug's Benefit-Risk Profile; Shares Down Pre-Bell	02:44pm	MT
GSK: FDA advisory committee turns down Blenrep	02:27pm
GSK falls as blood cancer drug likely headed for US rejection	02:11pm	RE
GSK falls as blood cancer drug likely headed for US rejection	02:11pm	RE
FTSE 100 edges up; Reckitt rises on home care sale	01:35pm	AN
GSK : Berenberg gives a Neutral rating	12:03pm	ZD
Joy in the Air	11:46am
Setback for GSK as Blenrep does not win US FDA committee support	11:32am	AN
GSK : JP Morgan gives a Sell rating	11:08am	ZD
US FDA Committee Advises Against Blenrep Combinations for Myeloma	09:03am	MT
GSK's blood cancer drug fails to secure US FDA advisers' support	18/07	RE
GSK : UBS gives a Neutral rating	18/07	ZD
FDA Committee Votes Against GSK Blood Cancer Drug Blenrep	18/07	DJ
FDA advisers vote against combination therapies of GSK's blood cancer drug	17/07	RE
European Equities Close Higher in Thursday Trading; EU Inflation Rises in June	17/07	MT
US FDA approves GSK's Shingrix in a prefilled syringe presentation	17/07	RE